sodium nitroprusside in 0.9% sodium chloride
sodium nitroprusside in 0.9% sodium chloride is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including sodium nitroprusside in 0.9% sodium chloride. Available dosage form: injection.
Drug Details
- Generic Name
- sodium nitroprusside in 0.9% sodium chloride
- Brand Names
- sodium nitroprusside in 0.9% sodium chloride
- Application Number
- ANDA215846
- Sponsor
- Slate Run Pharmaceuticals, LLC
- NDC Codes
- 3
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- SODIUM NITROPRUSSIDE
Indications and Usage
1 INDICATIONS AND USAGE Sodium nitroprusside is a direct acting vasodilator indicated for: Immediate reduction of blood pressure ( 1.1 ) Producing controlled hypotension to reduce bleeding during surgery ( 1.2 ) Treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure ( 1.3 ) 1.1 Immediate Reduction of Blood Pressure Sodium nitroprusside is indicated for the immediate reduction of blood pressure of adult and pediatric patients in hypertensive crises. 1.2 Induction and Maintenance of Controlled Hypotension Sodium nitroprusside indicated for induction and maintenance of controlled hypotension in adults and children during surgery, to reduce bleeding. 1.3 Treatment of Acute Heart Failure Sodium nitroprusside is indicated for the treatment of acute heart failure to reduce left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance and mean arterial blood pressure.